| Bioactivity | VIP236 is a small-molecule-drug conjugates (SMDCs) consisting of an αvβ3 integrin binder linked to an optimized Camptothecin (HY-16560) topoisomerase I (TOP1) inhibitor payload. VIP236 exerts anticancer activity by targeting αvβ3 integrins, and it can release payload upon cleavage by neutrophil elastase in the tumor microenvironment[1]. |
| CAS | 2418533-90-9 |
| Formula | C72H84N12Na2O20S |
| Molar Mass | 1515.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
VIP236
CAS: 2418533-90-9 F: C72H84N12Na2O20S W: 1515.55
VIP236 is a small-molecule-drug conjugates (SMDCs) consisting of an αvβ3 integrin binder linked to an optimized Campto
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.